SCM Pharma has entered an agreement with BrePco BioPharma to develop and manufacture an injectable neonatal product for clinical trials researching the treatment in critically ill premature babies suffering from hypotension.   SCM will initially produce development and clinical batches for eight clinical trial sites across Canada and Europe and then scale-up to commercial production if the product gets licensed. SCM has already manufactured engineering batches and will begin work on a stability ...